drugset / Trial / NCT00299156
Oral Clofarabine Study in Patients With Myelodysplastic Syndrome
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to learn if clofarabine given by mouth on a weekly schedule can help to control MDS. The safety of clofarabine given by mouth will also be studied.
Timeline
- Start
- 2006-03
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clofarabine | Other / unclassified | 10 mg | Oral |
| Subject | Clofarabine | Other / unclassified | 20 mg | Oral |